Cudrania tricuspidata is a perennial plant of the family Moraceae with numerous medicinal and nutritional applications. It has been widely used in East Asia as an important traditional folk medicine for the treatment of many ailments such as eczema, mumps, tuberculosis, contusions, insomnia and acute arthritis. The whole plant of C. tricuspidata, including the roots, leaves, bark, stems and fruits, has been found to contain diverse phytochemicals, including xanthones, flavonoids, organic acids, and polysaccharides, with various bioactivities. In particular, xanthones and flavonoids, as the main active constituents, isolated from C. tricuspidata have been proven to possess notable anti-inflammatory, antioxidative, antitumor, hepatoprotective, neuroprotective and anti-obesity effects. This review summarizes the botany, traditional uses, phytochemistry and pharmacology of C. tricuspidata, and the limitations of studies on this species have also been discussed such that to serve as the basis for further research and development on this medicinal plant.
Introduction
Cudrania tricuspidata (Carr.) Bur. ex Lavallee, which is a deciduous thorny tree belonging to the family Moraceae, is widespread throughout East Asia 1 and is known as cudrang, mandarin melon berry, silkworm thorn, storehouse bush, hariguwa (in Japanese) and che (in Chinese).
2-4 In China, C. tricuspidata roots have been used as 'Chuan-po-shi' in traditional Chinese medicine (TCM) in the treatment of gonorrhea, rheumatism, jaundice, boils, scabies, bruising, and dysmenorrhea; 5, 6 its root bark has been widely used in the treatment of lumbago, hemoptysis, and contusions; 7 and its roots and stems have also been applied in the forms of syrups, granules and injections to cure tumors of the digestive tract. 8 In Korea, C. tricuspidata has become one of the most ubiquitous folk remedies against cancer during the last few decades. 9 In addition to the above medical uses, in China the stems and roots of C. tricuspidata have been used to prepare herbal teas or functional beverages for a long period;
10 the stems, which contain a reddish-yellow dye, have been noted for their use in coloring imperial garments;
3 and the tender leaves of C. tricuspidata have been used as a perfect food for breeding silkworms since the Han dynasty, and the natural silk has been praised under the name of Zhe Si.
11 Its edible fruits have been made into juices, jams, alcoholic beverages, dietary supplements and other health products in Korea. 12 Moreover, its bark bers have been utilized to make paper and its trunks have been used as valuable timber for furniture manufacture.
13
The immense medicinal and economic value of C. tricuspidata has encouraged numerous studies of its phytochemicals and pharmacological activities. C. tricuspidata extracts have been demonstrated to possess good therapeutic effects against various ailments including inammation, 14, 15 tumors, 16, 17 obesity, 18, 19 and diabetes. 20, 21 Xanthones and avonoids have been considered to be the two major classes of phytochemicals in C. tricuspidata. For example, prenylated xanthones and avonoids were found to be the most important and abundant constituents in its leaves and root bark with regard to their notable anti-inammatory, 22, 23 antitumor, 16, 24 hepatoprotective, 25, 26 neuroprotective, 27, 28 and anticoagulant 29 activities; hydroxybenzyl avonoid glycosides from the stem bark were reported to be promising natural antioxidant and antitumor agents; 30 and prenylated isoavonoids and benzylated avonoids from the fruits displayed potential antiinammatory 31 and antioxidant 32 activities. Besides, a glycoprotein (75 kDa) from C. tricuspidata, which consisted of carbohydrate (72.5%) and protein moieties (27.5%), exhibited distinctive characteristics with anti-inammatory, 33 antioxidant, 34 hepatoprotective, 35 and immunomodulatory 36 effects. To date, to the best of our knowledge, no comprehensive review concerning C. tricuspidata has been available. A literature survey was conducted via an electronic search using PubMed, Scopus, ACS, Web of Science, ScienceDirect, China Knowledge Resource Integrated Database (CNKI), Google Scholar, SciFinder and a library search for ethnobotanical textbooks. The Plant List (www.theplantlist.org), the Missouri Botanical Garden's Tropicos nomenclature database (www.tropicos.org) and the Chinese Field Herbarium (www.c.ac.cn) were used to validate the taxonomy and also obtain information regarding subspecies and cultivars. On the basis of the literature search, we reviewed the achievements of research on the botanical characteristics, traditional uses, phytochemicals and pharmacological activities of C. tricuspidata so as to provide a systematic summary of the literature for further research on, and development of, this medicinal plant.
2 Botany and traditional uses of C. tricuspidata 2.1. Botany of C. tricuspidata C. tricuspidata is one of six species in the genus Cudrania, which is endemic to Asia and Oceania, of the family Moraceae in the order Urticales. 37 Five species, namely, C. tricuspidata, C. cochinchinensis (Lour.) Kudo et Masam, C. fruticosa (Roxb.) Wight ex Kurz, C. amboinensis (Bl.) Miq., and C. pubescens Trec., as well as C. cochinchinensis var. gerontogea (Nakai) Kudo et Masam, have been widely cultivated in Southern China, including Yunnan, Fujian and Jiangsu provinces, as well as in Hebei province, as protable plants for producing valuable fruits and timber. 38, 39 In Europe C. tricuspidata was introduced into cultivation in 1870, and in the USA in 1909. 40 In contrast, wild populations of this species are now under threat of extinction.
As a hardy deciduous plant, C. tricuspidata is widely distributed in lowlands, foothills, forests, or dense scrub at altitudes of between 500 and 2000 m. It can eventually grow to a height of approximately 1.0-7.0 m (Fig. 1 ), but oen exists as a broad spreading bush or small tree. Its leaves have single alternate ovate to rhombic-ovate blades with a size of 5.0-14.0 cm long and 3.0-6.0 cm wide; its owers have a dioecious capitulum with an inorescence length of 0.5 (male) or 1.0-1.5 cm (female); the color of its syncarpous fruits is orange-red when mature; and its roots, which are up to 50 cm long, are yellow and irregularly cylindrical. 
Traditional uses
Since ancient times, C. tricuspidata has been used as a folk medicine in oriental countries. 41 The medicinal material, which is known as Zhemu in TCM, is sweet in taste, slightly warm in nature and acts on the liver and spleen meridians in TCM theory. 42 Its medicinal usage was rst documented in Ben Cao Shi Yi (700-800 A.D., Tang Dynasty), which is a famous masterpiece of TCM, 42 followed by other Chinese medical classics such as Ben Cao Yan Yi (1116 A.D., Song Dynasty), 43 Ben Cao Hui Yan (1624 A.D., Ming Dynasty), 44 and the Dictionary of Chinese Herbal Medicine (2006 Edition).
6 Notably, C. tricuspidata roots, together with the roots of C. cochinchinensis (Lour.) Kudo et Masam, have been recorded as 'Chuan-po-shi' in the Chinese Pharmacopoeia (1977 Edition). 5 According to traditional applications and empirical practice, the bark of C. tricuspidata has mainly been used to strengthen the body and improve health conditions, and the trunk to invigorate the circulation of the blood and cure impaludism. 42 An aqueous decoction of its fruits and leaves (15-30 g ) could be taken orally to relieve rheumatoid arthritis. Scabies and eczema could be alleviated using a decoction of its roots mixed with the roots of C. cochinchinensis and glutinous rice. 45 An aqueous decoction of its roots combined with Acanthus ilicifolius L. and Desmodium pulchellum (L.) Benth. was documented to treat hepatitis, in particular viral hepatitis. 46, 47 Currently, the bark of C. tricuspidata, together with Zhemu syrup (a traditional Chinese patent medicine), is widely employed in TCM clinics for the treatment of cancer of the alimentary system, in particular gastric carcinoma. 8, 24 Speci-cally, C. tricuspidata has been widely used with a long folkloric medicinal history by Chinese nationalities including Yi, Wa, Tong, Bai and Yao.
In the Korean classic Donguibogam (1613 A.D., Joseon Dynasty), C. tricuspidata was recorded as treating eczema, mumps, tuberculosis, contusions, and acute arthritis. 48 Its fruits are commonly consumed in the Korean daily diet owing to its diverse biological effects, e.g., antioxidant, antiinammatory and immunomodulatory activities.
12 In addition, during the last few decades, the whole plant of C. tricuspidata has been exploited as an important folk remedy for cancer in Korea. 49 
Phytochemistry
Over recent decades, a large number of chemical constituents have been isolated from C. tricuspidata. Xanthones and avonoids have been recognized to be the main active and structurally diverse constituents responsible for the various activities of this species, followed by organic acids, polysaccharides, phenylpropanoids, and other constituents (Table 1) .
Xanthones (1-99)
The presence of abundant xanthones substituted by a variety of isoprenoid, phenolic and methoxy groups has been considered to be a taxonomic feature of C. tricuspidata (Fig. 2) . 17, 49, 50 Among these, from the perspective of the structure-activity relationship (SAR), xanthones substituted by isoprenoid groups display better biological activities. For instance, cudratricusxanthone A (CTXA, 1), cudraxanthones L (28) and M (29) , and macluraxanthone B (72) and neuraminidase-inhibiting effects.
53 Cudratricusxanthones B-E (2-5) and G (7), cudraxanthones D (20) , L and M, and macluraxanthones B and C (73) , which are classed as catecholic xanthones, could be converted into quinone methide intermediates in an enzymatic or a nonenzymatic manner 54 and were reported to have signicant antitumor activity. 17, 49, 55, 56 In addition, catecholic xanthones, specically cudraxanthone C (19) and 1,3,7-trihydroxy-4-(1,1-dimethyl-2-propenyl)-5,6-(2,2-dimethylchromeno)xanthone (84) , exhibited both potent superoxide-and hydroxyl radicalscavenging activities, which could be rationalized by their chelating effect with Fe 2+ ions.
56
It should be noted that investigations into quantitative analysis of the characteristic xanthones in C. tricuspidata are scarce. On the basis of HPLC analysis, cudratricusxanthones B, D and F (6) and macluraxanthone B in C. tricuspidata root bark were found to account for 0.017%, 0.026%, 0.025% and 0.071%, respectively. 57 The quantitative analysis of other xanthones in C. tricuspidata is worth investigating in the future.
Flavonoids (100-257)
Flavonoids account for the largest proportion of C. tricuspidata and have attracted particular interest because of their welldened pharmacological activities. To date, more than 120 avonoids (Fig. 2) have been isolated from C. tricuspidata and can be classied into avones (100-128), avanones (129-173), and isoavones (174-257). Structurally, the majority of them possess prenylated, benzylated, and methoxy groups substituted on their aromatic rings. Cudraavanone E (133), which is isolated from C. tricuspidata roots, features a rare avanone skeleton with the B-ring fused to a furan ring. 58 Lee et al. 16, 59 isolated a series of rare benzyl-substituted avonoids, i.e., gericudranins A-E (161-165), from C. tricuspidata. Notably, prenylated avonoids have been regarded as attractive specialized metabolites with diverse biological activities. Specically, cudraavone B (104), which is a prominent prenylated avonoid from the roots of C. tricuspidata, exhibited MAO-inhibiting, 50 antiatherosclerotic, 9 anti-inammatory, 60 hepatoprotective, 25 antitumor, 61 and neuroprotective 62 effects. Euchrestaavanones B (143) and C (144) displayed antibacterial activity against Gram-positive bacteria, Staphylococcus aureus, Bacillus subtilis and Bacillus cereus.
63
The investigation of the biosynthesis of the prenylavonoids in C. tricuspidata has been attempted. Dai et al. 64 established a cell suspension culture of C. tricuspidata for the enzymatic preparation of prenylavonoids. A avonoid prenyltransferase was identied as C. tricuspidata isoliquiritigenin 3 0 -dimethylallyltransferase. 64 This enzyme was found to be able to regioselectively introduce dimethylallyl diphosphate at the orthoposition of the phenolic moiety in the common 2,4-dihydroxyacetophenone substructure shared by the three types of avo-noids, i.e., chalcones, isoavones, and avones. 64, 65 These studies could improve our knowledge of the mechanism of the biosynthesis and accumulation of prenylated avonoids in C. tricuspidata.
The constituents and quantities of the avonoids in C. tricuspidata fruits have been demonstrated to change in accordance with their maturation stage. Unripe fruits of C. tricuspidata were found to have a higher content of total avo-noids in comparison with ripe fruits. An analysis of the chemical constituents revealed that avonoids with a side chain of cyclized prenyl 2,2-dimethylpyran rings were predominant in the unripe fruits, whereas avonoids with a linear prenyl side chain were the main constituents in ripe fruits.
66
Only a few studies have been reported concerning the quantitative analysis of representative avonoids in C. tricuspidata. By UV-vis spectrophotometry, the concentration of total avonoid glycosides in C. tricuspidata roots was measured to be up to 3.96 mg g À1 (as rutin equivalents). 67 By HPLC analysis, the avonoids kaempferol (118), quercetin (125) , naringenin (146) and taxifolin (166) in C. tricuspidata were found to occur at 0.30, 0.09, 1.94 and 0.63 mg g À1 in the roots and 0.08, 0.04, 0.90 and 0.62 mg g À1 in the stems, respectively. 68 Jeon et al. 69 reported the isolation of prenylated isoavonoids from an n-hexane extract of C. tricuspidata fruits using centrifugal partition chromatography and found that the main avonoids 4 0 -O-methylalpinumisoavone (242), 6,8-diprenylgenistein (252) and 6,8-diprenylorobol (254) amounted to 2.7%, 7.6% and 6.4%, respectively.
Organic acids (258-289)
To date, thirty-one organic acids and their esters have been isolated from C. tricuspidata. The stem extract was reported to contain n-hexanoic acid (278) in the greatest concentration (9.89 mg g À1 ) followed by 2-acetylpyrrole (405, 1.86 mg g À1 ), whereas the root extract was found to have n-hexanoic acid (13.13 mg g À1 ) in the greatest concentration followed by n-heptanoic acid (279, 2.05 mg g À1 ). 10 Jung et al. 70 reported that the levels of organic acids such as citric acid (261), malic acid (264), oxalic acid (265), succinic acid (270) and tartaric acid (273) in C. tricuspidata fruits varied with the maturation stage, and malic acid was the most abundant. immunomodulatory activities, namely, CTP-B1 (290), CTPS-01 (291), CPS-0 (292), CTPS-1A (293), CTPS-2B (294) and CTPS-3A (295), were obtained from the roots of C. tricuspidata.
72-74
Their backbones were revealed to be commonly substituted with a-D-glucuronic acid, 4-O-methyl-a-D-glucuronic acid, and neutral sugar units such as a-L-arabinose, a-D-xylose and a-Dgalactose. 10 Oxyresveratrol, as a representative phenylpropanoid, was isolated from the twigs of C. tricuspidata, exhibited potent inhibitory activity against mushroom tyrosinase and might serve as an anti-browning agent for food. In addition to the aforementioned components, a large number of other components have also been identied in C. tricuspidata. Twenty-nine compounds were identied in the essential oil of C. tricuspidata fruits, which accounted for 94.46% of the essential oil, such as demeton-O-methyl (364), diethyl phthalate (365), ethyl-N-methylcarbamate (366), indene (372), scyllitol (385), tridecanol (388) and 1-phenyl-1-cyclohexylethane (398).
76
It should be mentioned that a series of carotenoids were identied in C. tricuspidata fruits, including lycopene (374), lutein (375), phytouene (379), ruboxanthin (383), zeaxanthin (391), acarotene (428), b-carotene (429), neo-b-carotene (430) and polycopene (443). 77 
Pharmacological properties
Accumulated studies have revealed that the extracts and components of C. tricuspidata exhibited a broad spectrum of pharmacological activities, including anti-inammatory, 21, 52 effects. The presence of a variety of bioactive compounds may be synergistically or individually responsible for the various activities of this species (Fig. 3) . Among these, xanthones and avonoids are representative ingredients that mainly possess anti-inammatory, antioxidant and antitumor activities.
Anti-inammatory activity
There has been strong evidence that diseases associated with inammation may be ameliorated by C. tricuspidata. The anti- inammatory molecular mechanisms could be elucidated on the basis of the effects of the extracts and compounds from C. tricuspidata (Fig. 4) . It has been reported that a methanolic extract of C. tricuspidata could decrease the production of the pro-inammatory cytokines interleukin-2 (IL-2) and interferong (IFN-g) by selectively inhibiting the proliferation of anti-CD3/ CD28-mediated CD4 + CD25 À T-cells. 15 The chloroform (CHCl 3 ) fraction of C. tricuspidata was observed to inhibit the overproduction of nitric oxide (NO) and prostaglandin E 2 (PGE 2 ) by decreasing the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) and reducing the levels of tumor necrosis factor-a (TNF-a), IL-1b and IL-6 in RAW 264.7 mouse macrophage cells stimulated with lipopolysaccharide (LPS). 83 The ethyl acetate (EtOAc) fraction of the stem bark could suppress the production of NO and expression of iNOS in RAW 264.7 cells stimulated with IFN-g/LPS via the inactivation of nuclear factor-kB (NF-kB). 84 The EtOAc fraction of C. tricuspidata stem bark could inhibit the differentiation of osteoclasts stimulated by IL-1b and mediated by receptor activator of NF-kB ligand, the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and p38 mitogen-activated protein kinase (MAPK), and the expression of c-Fos and nuclear factor of activated T-cells c1 (NFATc1). 85 The EtOAc fraction of the whole plant was also found to reduce the expression of IL-1b, matrix metalloproteinases (MMPs), COX-2 and PGE 2 by inhibiting the phosphorylation of MAPK and the activation of NF-kB signalling pathways in rheumatoid synovial broblasts. 86 The above research suggested that C. tricuspidata may be useful for managing bone destruction in inammatory diseases, such as rheumatoid arthritis (RA).
Numerous compounds from C. tricuspidata possess noticeable anti-inammatory properties. Prenylated isoavones from the leaves of C. tricuspidata, including cudraisoavone L (184), wighteone (202) and furowanin B (215) exhibited potential antiinammatory activity by inhibiting the production of NO in LPS-stimulated RAW 264.7 cells, with inhibition values of 72.5 AE 2.4%, 66.9 AE 1.8%, and 55.4 AE 2.7% at a concentration of 10 mM, respectively. 87 It was found that the position of hydroxyl groups in the xanthone moiety was important for the NOinhibiting activity, and the catechol moiety was partially responsible for the inhibitory activity (Table 2) . 88 A C. tricuspidata glycoprotein suppressed the expression of iNOS and COX-2 via the regulation of NF-kB in LPS-stimulated RAW 264.7 cells.
34
The xanthone CTXA, as an effective inducer of heme oxygenase-1 (HO-1), signicantly inhibited the production of PGE 2 , NO, TNF-a, and IL-1b and increased the activity of HO in LPSstimulated RAW 264.7 macrophages. 22 Moreover, CTXA could exert anti-soluble endothelial cell protein C receptor (antisEPCR) shedding activity against vascular inammation via inhibiting the expression of TNF-a-converting enzyme induced by phorbol-12-myristate-13-acetate in endothelial cells.
89
Cudraavone B was not only a potent inhibitor of TNF-a by blocking the translocation of NF-kB from the cytoplasm to the nucleus in macrophages derived from a THP-1 human monocytic leukemia cell line, but was also an inhibitor of COX-1 and COX-2 with higher selectivity toward COX-2, which suggested that it could be used as a lead for the development of nonsteroidal anti-inammatory drugs.
60
Allergic inammation affects roughly one-quarter of people in the world. (254) not only interfered with the interaction between IgE and high-affinity IgE receptor (Fc3RI) and the expression of Fc3RIb mRNA but also inhibited the redistribution of F-actin and downstream signalling by suppressing the activation of Fc3RI-mediated spleen tyrosine kinase in mast cells, which was suggestive of therapeutic potential for controlling mast cell activation in allergic processes. 91 Treatment with the C. tricuspidata glycoprotein resulted in degranulation for allergic response (b-hexosaminidase) and the activation of MAPK/ activator protein-1 (AP-1) and NF-kB, as well as the expression of cytokines related to allergic inammation (IL-4, IL-6, TNF-a, IFN-g, and IL-1b), which are indirectly activated by bisphenol A or di(2-ethylhexyl) phthalate in HMC-1 and RBL-2H3 cells. 
Antioxidant activity
Evidence has mounted that C. tricuspidata could act as an efficient free-radical scavenger and thus help the antioxidant defense system (Table 3 ). C. tricuspidata leaves, in comparison with other parts, exhibited the highest scavenging activities against the 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2 0 -azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radicals and the highest ferric reducing/antioxidant power (FRAP), which was correlated with their high level of polyphenols (73.60 AE 0.28 mg g À1 ), in particular quercetin. 97, 98 It has been reported that C. tricuspidata leaves could produce more quercetin and kaempferol aglycones via Lactobacillus-mediated fermentation, which would increase antioxidant activities (DPPH and ABTS assays), and thereby could be developed as high-value-added food materials and functional foods. [99] [100] [101] [102] An aqueous extract of C. tricuspidata (2 mg mL À1 ) exhibited signicant scavenging activities of 50.2% (ABTS) and 40.5% (FRAP), respectively. 103 The antioxidant activity of C. tricuspidata fruits was revealed to change depending on the maturation stage and was positively associated with the contents of prenylavonoids such as artocarpesin (100), alpinumisoavone (198), 6-isopentenylgenistein (202), 4 0 -O-methylalpinumisoavone and 6,8-diprenylgenistein. 104 The prenyl group on the A-ring of isoavone was a potent contributor against the ABTS radical system. 105 The C. tricuspidata glycoprotein (100 mg mL À1 ) exhibited strong scavenging activities against DPPH, superoxide anions and hydroxyl radicals, with no pro-oxidant activity in vitro. 34 It should be interesting to investigate the in vivo antioxidant potentials of these compounds for preventing various radical-mediated injuries in pathological situations.
Antitumor activity
During recent decades, C. tricuspidata has been demonstrated to possess promising antitumor and cytotoxic activities, and its cortices and root bark have been widely employed in TCM clinics for the treatment of cancer of the alimentary system, in particular gastric carcinoma.
7,55
An EtOAc extract of C. tricuspidata stem bark displayed signicant cytotoxicity against HL-60 cells, and the mechanism underlying its cytotoxicity may be due to apoptosis. 106 A CHCl 3 extract of C. tricuspidata roots exhibited signicant cytotoxicity against human gastric carcinoma cell lines (SGC-7901 and BGC-823). 17 An MeOH extract of C. tricuspidata stems could induce the apoptosis of cervical cancer cells via the extrinsic pathway, as well as via the repression of human papillomavirus type-16 oncoproteins E6 and E7 and the alteration of p53 and p-pRb protein levels, instead of cytotoxicity. 107 In nude mouse models of B16 melanoma and human SK-OV3 xenograed tumors, the tumor-inhibiting rates of the total avonoids (250 mg kg À1 ) from C. tricuspidata were 50.54% and 46.38%, respectively.
108
Several compounds isolated from C. tricuspidata displayed considerable inhibitory activity against various tumor cells in an MTT assay ( Table 4 ). The isoprenylated xanthones 20, 28, and 29 exhibited potent cytotoxic activity against HL-60 cells owing to apoptosis in a DNA fragmentation assay.
56 Gericudranins A-E isolated from the stem bark of C. tricuspidata exhibited cytotoxicity against human tumor cell lines such as CRL1579 (skin), LOX-IMVI (skin), MOLT-4F (leukemia), KM12 (colon) and UO-31 (renal). 16, 58 The p-hydroxybenzyl moiety at C-6 was revealed to be essential for the cytotoxic activity. Cudraavone B was demonstrated to be a lead for the development of a potential candidate for treating human oral squamous cell carcinoma cells via the activation of MAPK and NF-kB, as well as the silent information regulator 1 (SIRT1) pathway.
61 Cudraxanthone H (24) 61 CTXA could suppress the migration and invasion of MCF-7 and MDA-MB-231 breast cancer cells by downregulating MMP-9 and induce apoptosis by activating the mitochondrial-associated apoptotic signalling pathway, which suggests that it may be a novel antitumor agent for breast cancer therapy. 114 Cudratricusxanthone G could inhibit the proliferation, migration and invasion of SW620 human colorectal carcinoma cells instead of displaying cytotoxicity by targeting MMP-2, thereby regulating the activation of Rac1, Cdc42 and their downstream target AP-1. 24 Notably, the chemical and biogenic synthesis and molecular modication of unique compounds isolated from C. tricuspidata have attracted attention. For example, from gericudranin A a series of derivatives were synthesized by structural modication, some of which exhibited strong cytotoxicity against several cancer cell lines such as SNB19, MOLT-4F, and K562 cells in a sulforhodamine B assay. 115 It is suggested that more attention should be paid to the SAR and in vivo antitumor mechanisms of the antitumor constituents of C. tricuspidata.
Hepatoprotective activity
Liver disease remains one of the most serious health problems without satisfactory drugs. The CHCl 3 fraction of an MeOH extract of C. tricuspidata root bark exhibited a signicant hepatoprotective effect on tacrine-induced cytotoxicity in HepG2 cells. 26 CTXA, cudratricusxanthone E, cudraxanthone L and macluraxanthone B, which were isolated from the CHCl 3 fraction, displayed the strongest hepatoprotective effects on tacrineinduced cytotoxicity in HepG2 cells at 10 mg mL À1 . 116 It was demonstrated that 1,1-dimethylallyl or 2,3,3-trimethyl-2,3-dihydrofuran moieties in the xanthones played important roles for the inhibitory activity. 116 The glycoprotein (75 kDa) isolated from C. tricuspidata fruits was effective in preventing CCl 4 -induced liver damage in A/J mice by signicantly increasing the activities of superoxide dismutase, catalase, and glutathione peroxidase, as well as decreasing the production of TBARS, lactate dehydrogenase (LDH) and NO. 35 These constituents might be preferred alternatives for liver disease, and in vivo assays are essential to ascertain their hepatoprotective role fully.
Neuroprotective activity
An aqueous extract of C. tricuspidata roots exhibited a stronger protective effect against neurotoxicity induced by oxidative stress than those of leaves, stems, and fruits, which was correlated with its high level of phenolic compounds, in particular kaempferol, myricetin (123) and quercetin.
117 CTXA and cudraavone B displayed signicant neuroprotective activity against glutamate-induced neurotoxicity via the induction of HO-1 in HT22 mouse hippocampal cells. 51, 62 The neuroprotective effect of cudraavone B was probably regulated by the phosphatidylinositol 3-kinase (PI3K)/AKT pathways.
62
MAOs are responsible for the degradation of neurotransmitters including noradrenaline, dopamine, and 5-hydroxytryptamine in the central nervous system.
118
The dichloromethane (CH 2 Cl 2 ) fraction of C. tricuspidata fruits was active in inhibiting mouse brain MAO, and gancaonin A (216), 
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The neuroprotective potential of the avonoids orobol (230), 6-prenylorobol (255) and 6,8-diprenylorobol was evaluated via enhancing the ubiquitin/proteasome-dependent degradation of a-synuclein and synphilin-1 in SH-SY5Y human neuroblastoma cells induced by 6-hydroxydopamine (6-OHDA) (Table 5) , which signied that they might be possible candidates for the treatment of neurodegenerative diseases. 119 5,7-Dihydroxychromone (426) could prevent 6-OHDA-induced oxidative stress and apoptosis in SH-SY5Y cells via the activation of the Nrf2/ARE signalling pathway and the overexpression of antioxidant enzymes, including HO-1, NAD(P)H: quinone oxidoreductase and the glutamate-cysteine ligase catalytic subunit. 120 In LPSstimulated BV2 mouse microglia, CTXA (IC 50 ¼ 0.98 mM) decreased the production of TNF-a, IL-1b, and IL-12, inhibited the phosphorylation and degradation of IkB-a, and blocked the nuclear translocation of p50 and p65 by inhibiting the NF-kB and MAPK pathways.
121 Cudraavanone D (132) could suppress the production of NO in LPS-induced BV2 microglial cells with an IC 50 value of 6.28 mM and exert anti-neuroinammatory activity by targeting iNOS and COX-2 via the MAPK and NF-kB pathways.
1 Demethylsuberosin (299), as a potent proteasome activator, attenuated the 1-methyl-4-phenylpyridinium-induced dysfunction of the chymotrypsin-like and caspase-like activities of proteasomes in SH-SY5Y cells with EC 50 values of 0.76 mM and 0.82 mM, respectively, and protected SH-SY5Y cells against 1-methyl-4-phenylpyridinium-induced cell death, with an EC 50 value of 0.17 mM. 
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The above results demonstrated that those compounds with neuroprotective activities could be considered as candidates for further research for therapeutic purposes into neurodegenerative diseases such as Parkinson's disease.
Antiobesity activity
Excess body weight and obesity are severe threats to public health worldwide. The leaves of C. tricuspidata, in comparison with other parts, exhibited the most pronounced inhibitory effect against pancreatic lipase (PL), which is a key enzyme for lipid absorption, with an IC 50 value of 9.91 mg mL À1 in vitro, and were able to reduce plasma triacylglycerol levels and delay dietary fat absorption in vivo. 18 The optimal conditions for the maximum PL-inhibiting activity and extraction yield of C. tricuspidata fruits were determined using response surface methodology to be an ethanol concentration of 74.5%, a temperature of 61.9 C, and an extraction time of 13.5 h.
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Flavonoids isolated from C. tricuspidata, namely, cudraavanones A and D and 5,7,4 0 -trihydroxy-6,8-diprenylisoavone, inhibited PL, with IC 50 values of 9.0, 6.5, and 65.0 mM, respectively. 12, 124 Further SAR studies highlighted that the prenyl moiety and number and position of hydroxyl groups of the avonoids seemed to affect the PL-inhibiting activity, which needs to be claried using more derivatives. The PL-inhibiting activity of C. tricuspidata fruits has been proven to vary with their maturation stage. 66 Unripe fruits of C. tricuspidata, in accordance with their higher content of total phenolic compounds and avonoids, exhibited stronger PL-inhibiting activity in comparison to ripe fruits. 66 In addition, an isoavone, namely, cudracusisoavone B (195), from unripe fruits exhibited strong PL-inhibiting activity, with an IC 50 value of 16.8 mM, in a non-competitive manner.
66 Therefore, the maturation stage is an important factor for the efficacy, and unripe fruits appeared to be a good source of agents for the regulation of obesity. Protein-tyrosine phosphatases (PTP1B) are also important risk factors for obesity-related metabolic diseases. The leaves of C. tricuspidata displayed a strong inhibitory effect against PTP1B and substantially inhibited fat accumulation in 3T3-L1 cells in a dose-dependent manner. 19 Xanthones and avonoids isolated from the roots of C. tricuspidata, including CTXA, cudratricusxanthones L (12) and N (14), cudracuspixanthone A, cudraxanthones D, L, and M, macluraxanthone B, 1,6,7-trihydroxy-2-(1,1-dimethyl-2-propenyl)-3-methoxyxanthone (87), cudraavone C (105), kuwanon C (114), cudraavanone D and euchrestaavanone C, displayed a signicant inhibitory activity against PTP1B in a dosedependent manner, with IC 50 values ranging from 1.9 to 13.6 mM. 125 In comparison with avonoids, prenylated xanthones displayed stronger PTP1B-inhibiting effects, which suggested that they may be promising agents for the future discovery of novel PTP1B inhibitors.
An aqueous extract of C. tricuspidata leaves that underwent fermentation mediated by lactic acid bacteria was proven to be benecial for promoting osteogenic differentiation of osteoblastic cells and inhibiting fat accumulation in adipocytes. 99 In diet-induced obesity (DIO) mice, this extract could decrease levels of aspartate aminotransferase, alanine aminotransferase, total fat mass, triglycerides, and blood glucose and was also found to promote the phosphorylation of IRS-1 and Akt in liver tissues and improve insulin secretion.
19 Correspondingly, the leaves of C. tricuspidata could be used as materials to produce a functional food product with antiobesity effects. 126 6,8-Diprenylgenistein, which is a avonoid isolated from C. tricuspidata, was proven to decrease body weight, epididymal fat and serum triglyceride levels in DIO mice. 127 The underlying mechanism of this compound has been demonstrated, namely, that it could inhibit lipogenic genes by the regulation of transcription factors such as peroxisome proliferator-activated receptor g (PPARg) and CCAAT/enhancer-binding protein a (C/EBPa) and hormones such as leptin and adiponectin. 127 6,8-Diprenylgenistein was also found to regulate acetyl-CoA carboxylase (ACC) and hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) by the activation of AMP-activated protein kinase (AMPK).
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Further investigation is warranted to determine whether their benecial effects are associated with gut microbiota, which is a topic of recent and growing interest.
Immunomodulatory effects
Emerging evidence has suggested that C. tricuspidata is a potent immunomodulator. An aqueous extract of C. tricuspidata displayed potent adjuvant activity to enhance antigen-specic antibody responses and cellular immune responses against keyhole limpet hemocyanin. 128 In recent years, plant polysaccharides have emerged as an important class of bioactive natural products that are ideal therapeutic candidates for immunomodulatory functions with low toxicity. The in vitro immunomodulatory activities of the polysaccharides from C. tricuspidata roots were investigated in relation to the activation of mouse peritoneal macrophages.
71, 74 The results showed that the four water-soluble polysaccharides, namely, CTPS-1A, CTPS-2B, CTPS-3A, and CTP-B1, could directly stimulate the proliferation of mouse splenocytes alone or in combination with concanavalin A or LPS within the concentration range of 6.25 to 100 mg mL À1 , in a comparable way to the immunomodulator lentinan. 71,74 T-helper type 1 (Th1) and Th2 cytokines have been demonstrated to interact reciprocally to maintain a balanced immune network. The C. tricuspidata glycoprotein could prevent the development of immune diseases related to Th2 cell responses, such as autoimmune diseases, viral infections, and allergies. 36, 129 The precise mechanism of the differentiation of Th cells into Th1 or Th2 cells as induced by the C. tricuspidata glycoprotein remains to be elucidated.
Antiatherosclerotic activity
CTXA from C. tricuspidata was found to exert inhibitory effects on the synthesis and proliferation of DNA in vascular smooth muscle cells stimulated by platelet-derived growth factor (PDGF)-BB by suppressing the PDGF receptor b-chain and downregulating the Ras-Raf-MEK-ERK1/2 signalling pathways, and may serve as an antiatherosclerotic lead compound.
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Likewise, cudraavanone A was useful in the prevention of atherosclerosis or restenosis aer angioplasty, and the molecular mechanism was found to be that it inhibited the PDGF-BBinduced growth of rat aortic smooth muscle cells via an Aktdependent pathway.
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In addition, cudraavone B was observed to inhibit the proliferation of rat aortic smooth muscle cells by inducing the expression of p21 cip1 and p27 kip1 and subsequent cell cycle arrest with a reduction in the phosphorylation of pRb at the G1-S phase, which suggests its therapeutic potential for treating cardiovascular disease. 9 Low-density lipoprotein (LDL) has been known to play a crucial role in the development of atherosclerosis and hypercholesterolemia.
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Many compounds isolated from C. tricuspidata have been conrmed to be effective in preventing the oxidation of LDL in a TBARS assay (Table 3) .
Antimicrobial activity
The essential oil of C. tricuspidata fruits was proven to be able to disrupt the membrane functions of both Gram-positive and Gram-negative bacteria, which led to its effective use as a natural antimicrobial agent to control food-borne pathogens in the food industry. The antibacterial activity of the essential oil was investigated against Bacillus cereus ATCC 13061, Staphylococcus aureus ATCC 12600, Listeria monocytogenes ATCC 7644, Salmonella typhimurium ATCC 43174 and Escherichia coli O157:H7 ATCC 43889. 76 The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the essential oil were in the range of 250-500 mg mL À1 and 500-1000 mg mL À1 , respectively. 76 In addition, a methanolic extract of C. tricuspidata roots exhibited high antifungal activity against Gymnosporangium haraeanum Syd., Pyricularia oryzae Cav., Rhizoctonia solani Kühn, and Colletotrichum graminicola (Ces.) Wilson, with EC 50 values of 803, 997, 981 and 930 mg mL À1 , respectively. 
Skin protection
Atopic dermatitis (AD) is a chronic inammatory skin disease characterized by elevated immunoglobulin E (IgE) levels, mast cell inltration and skin lesions including pruritus, erythema and eczema. 131 An ethanolic extract of C. tricuspidata stems could be applied topically to decrease serum IgE levels and mast cell counts in the dermis of the skin in an AD-like NC/Nga mouse model induced by Dermatophagoides farinae extract.
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Similarly, an aqueous extract of C. tricuspidata fruits was also found to inhibit the development of AD-like skin lesions induced by repeated applications of D. farinae in sensitized NC/ Nga mice by reducing plasma concentrations of mouse thymus and activation-regulated chemokine (mTARC), histamine and IgE.
132 Nevertheless, the denite active compounds responsible for the anti-atopic dermatitis activity remain to be identied.
A methanolic extract of C. tricuspidata stems was demonstrated to prevent skin inammation and skin aging via suppressing the solar ultraviolet-induced expression of COX-2. 82 The EtOAc fraction (IC 50 ¼ 24.4 ppm) and the n-BuOH fraction (IC 50 ¼ 88.3 ppm) of the C. tricuspidata stem extract could reduce the activity of tyrosinase and the melanin content in a concentrationdependent manner. 79 It was found that the avonoids steppogenin (149, IC 50 ¼ 2.52 mM) and trans-dihydromorin (160, IC 50 ¼ 21.54 mM) and the phenylpropanoid oxyresveratrol (IC 50 ¼ 2.85 mM) from the twigs of C. tricuspidata displayed potent inhibitory activities against mushroom tyrosinase and the melanogenesis process in melanocytes, which suggested their potential to be developed as skin-whitening agents in cosmetics and antibrowning agents in food. 75 The tyrosinase-inhibiting activity of the avonoids could be affected by the hydroxyl groups substituted at the 2-and 4-positions of the aromatic ring. 75 Oxyresveratrol and trans-dihydromorin, as hypopigmenting agents, could induce post-transcriptional degradation of microphthalmia-associated transcription factor (MITF), leading to signicant decreases in the production of tyrosinase-related protein 1 (TRP-1) and tyrosinase-related protein 2 (TRP-2) in b16 and melan-a cells. 133 Besides, 6,8-diprenylorobol and pomiferin (233) could inhibit the photooxidation of A2E, which is an important constituent of lipofuscin in the retinal pigment epithelium, in a dose-dependent manner. 32 Collectively, these studies clearly showed that C. tricuspidata and the isolated bioactive compounds could be used as cosmeceutical materials and food constituents for the promotion of skin health.
Antidiabetic activity
Lee et al. 20 reported that the aqueous extract of C. tricuspidata leaves could signicantly improve hepatic insulin resistance and hyperglycemia by controlling obesity-induced stress in the hepatic endoplasmic reticulum and inammation in the liver of db/db mice. Furthermore, an in vitro study demonstrated that both C. tricuspidata leaves and the isolated compound kaempferol could reduce hepatic insulin resistance by suppressing insulin receptor substrate signalling and the inammatory response in HepG2 cells induced by endoplasmic reticulum stress. 134 In addition, the a-glucosidase-inhibiting activities of aqueous extracts of C. tricuspidata stems and roots depended on the harvesting time and climate. 21 A root extract exerted potent inhibitory effects on a-glucosidase activity, with 77% inhibition at a concentration of 300 mg mL À1 , which signied that the root could serve as an antidiabetic biomaterial. 21 Xanthones, including CTXA, cudratricusxanthone F, cudraxanthones D and L, macluraxanthone B, 1,3,6,7-tetrahydroxy-2-(3-methylbut-2-enyl)-8-(2-methylbut-3-en-2-yl)-9H-xanthen-9-one (83) and 1,3,7-trihydroxy-4-(1,1-dimethyl-2-propenyl)-5,6-(2,2-dimethylchromeno)xanthone (84) , displayed inhibitory activities against a-glucosidase, with IC 50 values of 16.2-52.9 mM.
52 CTXA was also proven to prevent the production of NO, the expression of iNOS, and the activation of JAK/STAT and NF-kB in RINm5F cells induced by IL-1b and IFN-g and to inhibit the glucosestimulated secretion of insulin in pancreatic islets. 135 The above results suggested that C. tricuspidata may be a promising therapeutic material in the treatment of diabetes.
Others
Besides the above pharmacological properties, other biological activities of C. tricuspidata have also been reported. An aqueous extract of C. tricuspidata stems could decrease systolic blood pressure in hypertension induced by N G -nitro-L-arginine methyl ester, in part by enhancing the generation of vascular NO/cGMP and the amelioration of renal functions. 136 The anticoagulant activity of CTXA was investigated by Yoo et al., 29 who revealed that CTXA could inhibit the generation of cell-based thrombin, activated factor X (FXa) and thrombin and exhibited thrombolytic activity by decreasing the ratio of plasminogen activator inhibitor type 1 (PAI-1) to tissue-type plasminogen activator (t-PA).
Park et al. 53 revealed that xanthones bearing 6,7 vicinal dihydroxy groups on the A ring, including CTXA, cudratricusxanthone F, cudraxanthones D, L and M, macluraxanthone B, and 1,3,6,7-tetrahydroxy-2-(3-methylbut-2-enyl)-8-(2-methylbut-3-en-2-yl)-9H-xanthen-9-one, displayed nanomolar inhibitory activity (IC 50 : 80-270 nM) against neuraminidase. Cudraavanone A, which bears a C-8 hydrated prenyl group, also displayed high neuraminidase-inhibiting activity, with an IC 50 of 380 nM. 137 This implied that these xanthones and avonoids may be potential antiviral agents in the future.
The above descriptions indicated that many compounds have a variety of activities, in particular CTXA, which is a major and important component with a wide range of activities. Recently, pharmacokinetic studies of representative constituents of C. tricuspidata have also attracted attention. The in vitro metabolic proling of CTXA in human liver microsomes has been recently investigated, which revealed that eight identied metabolites of CTXA were involved with cytochrome P450 enzymes (CYPs) and uridine 5 0 -diphospho-glucuronosyltransferase enzymes (UGTs). 138 In a follow-up study, CTXA has been demonstrated to exhibit reversible competitive inhibition of CYP1A2 and CYP2C9 and non-competitive inhibition of CYP2C8 in human liver microsomes, which has begun to shed light on the in vivo metabolism of CTXA.
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Cudratricusxanthone B, as another example, has also been investigated for its pharmacokinetics by a fast and sensitive HPLC-MS/ MS method, but its oral bioavailability (OB) remains unclear and merits future investigation.
140 Therefore, it is suggested that the pharmacokinetics of this plant should be studied systematically.
Conclusions
This review provides an up-to-date and comprehensive summary concerning the botany, traditional uses, phytochemistry and pharmacology of the traditional folk medicine C. tricuspidata. As a medicinal plant, C. tricuspidata has been used to treat rheumatism, bruising, scabies, hepatitis, jaundice, gonorrhea, dysmenorrhea and amenorrhea in East Asia for thousands of years. During the last few decades, C. tricuspidataderived extracts and compounds have attracted much attention for their promising biological activities, including antiinammatory, antioxidant, antitumor, hepatoprotective, immunomodulatory, neuroprotective, antiobesity, antimicrobial, antiatherosclerotic, skin-protecting, and antidiabetic activities. Obviously, some pharmacological activities are not related to the traditional uses of this species but provide valuable hints for new areas of application. Xanthones and avo-noids are the two major classes of constituent that contribute either directly or indirectly to the biological effects of C. tricuspidata, followed by minor classes, including organic acids, polysaccharides, phenylpropanoids, and others. Findings and knowledge regarding the phytochemistry and pharmacology of C. tricuspidata have established a basis for further research on, and development of, this medicinal plant and its active components. Notably, the unique structures isolated from C. tricuspidata have aroused interest in research on the chemical and biogenic synthesis of these bioactive compounds that is suitable for large-scale preparation and molecular modication. This should be benecial for the development and application of natural compounds from C. tricuspidata and their synthetic analogues. As a rich source of medicines and functional foods, quality control of C. tricuspidata is crucial to ensure both safety and efficacy. It is suggested that current advances, including mass spectrometry-based chemical proling and DNA barcoding, should be used to authenticate, differentiate, and evaluate the quality of C. tricuspidata. Importantly, a common international criterion should be established with the ultimate goal of ensuring the effectiveness and safety and maximizing the medicinal benets of C. tricuspidata.
As recent insights into the pharmacological mechanisms of C. tricuspidata are limited to in vitro bioassays of a limited number of molecules, it is essential and urgent to investigate the mechanisms of the bioactive extracts/isolates in appropriate animal models. To the best of our knowledge, few relevant data from clinical trials of C. tricuspidata (only in Chinese clinics) have been reported, and most clinical trials used a relatively small sample size and insufficient information. It is suggested that the efficacy of C. tricuspidata should be assessed in the future by combining its pharmacological effects, mechanisms of action and clinical applications. Detailed studies of the pharmacokinetics and toxicological properties and preclinical and clinical trials of C. tricuspidata are also eagerly awaited. More knowledge should be accumulated concerning the bioavailability, metabolism and toxicity of C. tricuspidata, which will be valuable for understanding its dosage efficacy and in vivo effects. It should be noted that the interaction between the bioactive constituents of C. tricuspidata and the human microbiota is an underappreciated aspect, as the gut microbiota plays a vital role in the pathogenesis and progression of obesity, diabetes and related metabolic disorders. 141 Current ndings have demonstrated that C. tricuspidata may serve as a good source of prebiotics that promote the growth of probiotic bacteria and improve the antioxidant activity of dairy products, which is of great interest for the development of functional foods.
